Company intelligence / Profile preview

Asecud

Lausanne, Vaud, Switzerlandasecud.com ↗

Ownership: Private
Development stage: Commercial

Overview

Asecud SA provides advanced biosensing technologies for transformative in-vitro diagnostics, combining assay development with state-of-the-art additive manufacturing and systems engineering. The company emphasizes high performance, process automation, design flexibility, cost reduction, and quality control in its solutions. There are no published clinical results as the company focuses on diagnostic devices rather than drugs.

Modalities: Diagnostic deviceIn-vitro diagnostic assay
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Asecud.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asecud.

Explore the full profile